Phase II evaluation of fludarabine in patients with metastatic breast cancer: A Southeastern Cancer Study Group trial

J. T. Carpenter, C. L. Vogel, G. Wang, M. Raney

Research output: Contribution to journal › Article

Cite this

@article{744940b1f6834f9dbcad18449d60c0c8,

title = "Phase II evaluation of fludarabine in patients with metastatic breast cancer: A Southeastern Cancer Study Group trial",

author = "Carpenter, {J. T.} and Vogel, {C. L.} and G. Wang and M. Raney",

year = "1986",

month = jan,

day = "1",

language = "English (US)",

volume = "70",

pages = "1235--1236",

journal = "Journal of the National Cancer Institute",

issn = "0027-8874",

publisher = "Oxford University Press",

number = "10",

}

TY - JOUR

T1 - Phase II evaluation of fludarabine in patients with metastatic breast cancer

T2 - A Southeastern Cancer Study Group trial

AU - Carpenter, J. T.

AU - Vogel, C. L.

AU - Wang, G.

AU - Raney, M.

PY - 1986/1/1

Y1 - 1986/1/1

UR - http://www.scopus.com/inward/record.url?scp=0022454374&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0022454374&partnerID=8YFLogxK

M3 - Article

C2 - 2428493

AN - SCOPUS:0022454374

VL - 70

SP - 1235

EP - 1236

JO - Journal of the National Cancer Institute

JF - Journal of the National Cancer Institute

SN - 0027-8874

IS - 10

ER -